All posts
-
Edible aquatic robots could be eaten by fish to eliminate waste
If you’re releasing a robot into the aquatic environment with no intention of retrieving it, that bot had better be biodegradable. Swiss scientists have gone a step better th…
-
Robot Talk Episode 120 – Evolving robots to explore other planets, with Emma Hart
Claire talked to Emma Hart from Edinburgh Napier College concerning formulas that ‘develop’ much better robotic layouts and control systems. Emma Hart is a computer sys…
-
Research at risk: Protecting national defense from cyberattacks
A Cornell-led analysis of susceptabilities in the semiconductor supply chain and exactly how to alleviate them gets on hold after obtaining a stop-work order.
-
U.S. Container Imports Predicted to Slump this Year Because of Tariffs
Imports have actually risen given that last summertime, initially as sellers generated freight in advance of an October strike at united state ports, after that in expectancy of a …
-
Fortune Minerals reports NICO bismuth project test work results for planned Alberta refinery
Ton Of Money Minerals (TSX: FEET) reported Friday that metallurgical examination job recognition is total for the bismuth circuits for the business’s 100% had NICO essential …
-
Side effects from Valneva’s chikungunya vaccine could make “noise” for Bavarian Nordic
In the short-term, French Valneva’s difficulties can affect the assumption of chikungunya vaccinations. However Bavarian Nordic anticipates the circumstance to finish in the …
-
Gubra to test new anti-obesity candidate in humans next year
Gubra chief executive officer Henrik Blou likewise specifies that the firm has strategies to locate a companion for the brand-new prospect. Nevertheless, he can not state when that…
-
Former WSA CEO to become chief exec at Sonova
The firm’s present chief executive officer has actually needed to tip down for health and wellness factors connecting to a relative.
-
Genmab CEO predicts billion-dollar sales from three drug candidates
In spite of a shelved task that has actually stressed experts, Genmab anticipates considerable development chances in 3 various other medications.
-
Bavarian Nordic retains full-year guidance
The Danish vaccine company notes big increases in both important business legs in the first quarter of the year. Nevertheless, the outlook remains unchanged.
